MedPath

ENGLEWOOD HOSPITAL AND MEDICAL CENTER FOUNDATION INC.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

23

Active:0
Completed:8

Trial Phases

4 Phases

Early Phase 1:1
Phase 2:3
Phase 4:1
+1 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (21 trials with phase data)• Click on a phase to view related trials

Not Applicable
16 (76.2%)
Phase 2
3 (14.3%)
Early Phase 1
1 (4.8%)
Phase 4
1 (4.8%)

Pilot Study Evaluating the Advantages of Sucrosomial® Iron Post-operative Supplementation vs Standard of Care After Cardiac Surgery

Early Phase 1
Not yet recruiting
Conditions
Cardiac Surgery
First Posted Date
2025-05-14
Last Posted Date
2025-05-14
Lead Sponsor
Englewood Hospital and Medical Center
Target Recruit Count
40
Registration Number
NCT06970925
Locations
🇺🇸

Englewood Hospital, Englewood, New Jersey, United States

Outcomes of Ablation of Unresectable Pancreatic Cancer Using the NanoKnife Irreversible Electroporation System-

Recruiting
Conditions
Pancreatic Cancer Non-resectable
First Posted Date
2025-04-22
Last Posted Date
2025-06-17
Lead Sponsor
Englewood Hospital and Medical Center
Target Recruit Count
25
Registration Number
NCT06937996
Locations
🇺🇸

Englewood Hospital, Englewood, New Jersey, United States

Novel Method to Assess Hepatic Regeneration and Predict Hepatic Related Morbidity After Partial Hepatectomy

Not Applicable
Not yet recruiting
Conditions
Liver Cancer Adult
Liver Regeneration
First Posted Date
2024-11-08
Last Posted Date
2025-04-13
Lead Sponsor
Englewood Hospital and Medical Center
Target Recruit Count
125
Registration Number
NCT06681818
Locations
🇺🇸

Englewood Hospital, Englewood, New Jersey, United States

Minimally Invasive Treatment of Primary Great Saphenous Vein (GSV) Insufficiency Using High Intensity Focused Ultrasound (HIFU)

Not Applicable
Completed
Conditions
Great Saphenous Vein Insufficiency
First Posted Date
2022-01-18
Last Posted Date
2023-04-19
Lead Sponsor
Englewood Hospital and Medical Center
Target Recruit Count
20
Registration Number
NCT05193643
Locations
🇺🇸

Englewood Health, Englewood, New Jersey, United States

Comparing Olanzapine and Mirtazapine in the Improvement of Unintentional Weight Loss for Patients With Advanced Stage Cancer

Phase 2
Conditions
Anorexia Nervosa with Significantly Low Body Weight
Interventions
First Posted Date
2021-12-28
Last Posted Date
2022-07-26
Lead Sponsor
Englewood Hospital and Medical Center
Target Recruit Count
170
Registration Number
NCT05170919
Locations
🇺🇸

Englewood Health, Englewood, New Jersey, United States

  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • Next

News

High Out-of-Pocket Costs Linked to Lower Cardiac Rehabilitation Adherence, Study Finds

A recent study published in The American Journal of Managed Care reveals that patients facing higher out-of-pocket expenses show decreased adherence to cardiac rehabilitation programs.

In-Home Rehabilitation Shows Promise Despite Healthcare System Barriers

High-intensity home-based rehabilitation programs demonstrate improved patient outcomes and lower costs compared to traditional inpatient facilities, according to recent research.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.